​
​

Legend Biotech (LEGN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Legend Biotech Revenue Highlights

Latest Revenue (Y)

$285.14M

Latest Revenue (Q)

$93.99M

Main Segment (Y)

Joint Steering Committee Service

Main Geography (Y)

UNITED STATES

Legend Biotech Revenue by Period

Legend Biotech Revenue by Year

DateRevenueChange
2023-12-31$285.14M143.70%
2022-12-31$117.00M30.31%
2021-12-31$89.79M18.65%
2020-12-31$75.68M32.15%
2019-12-31$57.26M16.55%
2018-12-31$49.13M-

Legend Biotech generated $285.14M in revenue during NA 2023, up 143.70% compared to the previous quarter, and up 580.35% compared to the same period a year ago.

Legend Biotech Revenue by Quarter

DateRevenueChange
2024-03-31$93.99M18.28%
2023-12-31$79.46M-17.24%
2023-09-30$96.01M30.93%
2023-06-30$73.33M101.81%
2023-03-31$36.34M31.49%
2022-12-31$27.63M0.99%
2022-09-30$27.36M128.56%
2022-06-30$11.97M-70.68%
2022-03-31$40.83M4.70%
2021-12-31$38.99M130.99%
2021-09-30$16.88M-16.56%
2021-06-30$20.23M47.88%
2021-03-31$13.68M-66.45%
2020-12-31$40.78M247.18%
2020-09-30$11.75M1.27%
2020-06-30$11.60M0.47%
2020-03-31$11.55M-40.64%
2019-12-31$19.45M10.05%
2019-09-30$17.67M75.22%
2019-06-30$10.09M0.34%
2019-03-31$10.05M-

Legend Biotech generated $93.99M in revenue during Q1 2024, up 18.28% compared to the previous quarter, and up 340.14% compared to the same period a year ago.

Legend Biotech Revenue Breakdown

Legend Biotech Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21Dec 20
Joint Steering Committee Service$54.52M$46.78M
Licensing Of Intellectual Property$4.91M$5.63M

Legend Biotech's latest annual revenue breakdown by segment (product or service), as of Dec 21: Joint Steering Committee Service (91.75%), and Licensing Of Intellectual Property (8.25%).

Legend Biotech Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
UNITED STATES$234.73M$116.60M$86.37M-
Europe$15.07M---
CHINA$179.00K$328.00K$3.42M-
Other Countries-$75.00K--
North America---$75.68M

Legend Biotech's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (93.90%), Europe (6.03%), and CHINA (0.07%).

Legend Biotech Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALNYAlnylam Pharmaceuticals$1.83B$420.15M
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
APLSApellis Pharmaceuticals$366.28M$176.57M
LEGNLegend Biotech$285.14M$93.99M
ZLABZai Lab$266.72M$100.50M
ASNDAscendis Pharma$266.72M$95.89M
BPMCBlueprint Medicines$249.38M$128.18M
TVTXTravere Therapeutics$145.24M$62.90M
ACLXArcellx$110.32M$26.03M
STOKStoke Therapeutics$8.78M$4.89M
PLRXPliant Therapeutics$1.58M-
KRTXKaruna Therapeutics$654.00K-
PCVXVaxcyte--
DAWNDay One Biopharmaceuticals-$20.07M
MDGLMadrigal Pharmaceuticals-$62.17M
TERNTerns Pharmaceuticals--
ETNB89bio--
AKROAkero Therapeutics--

LEGN Revenue FAQ

What is Legend Biotech’s yearly revenue?

Legend Biotech's yearly revenue for 2023 was $285.14M, representing an increase of 143.70% compared to 2022. The company's yearly revenue for 2022 was $117M, representing an increase of 30.31% compared to 2021. LEGN's yearly revenue for 2021 was $89.79M, representing an increase of 18.65% compared to 2020.

What is Legend Biotech’s quarterly revenue?

Legend Biotech's quarterly revenue for Q1 2024 was $93.99M, a 18.28% increase from the previous quarter (Q4 2023), and a 158.67% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $79.46M, a -17.24% decrease from the previous quarter (Q3 2023), and a 187.57% increase year-over-year (Q4 2022). LEGN's quarterly revenue for Q3 2023 was $96.01M, a 30.93% increase from the previous quarter (Q2 2023), and a 250.91% increase year-over-year (Q3 2022).

What is Legend Biotech’s revenue growth rate?

Legend Biotech's revenue growth rate for the last 3 years (2021-2023) was 217.56%, and for the last 5 years (2019-2023) was 397.94%.

What are Legend Biotech’s revenue streams?

Legend Biotech's revenue streams in c 21 are Joint Steering Committee Service, and Licensing Of Intellectual Property. Joint Steering Committee Service generated $54.52M in revenue, accounting 91.75% of the company's total revenue, up 16.56% year-over-year. Licensing Of Intellectual Property generated $4.9M in revenue, accounting 8.25% of the company's total revenue, down -12.80% year-over-year.

What is Legend Biotech’s main source of revenue?

For the fiscal year ending Dec 21, the largest source of revenue of Legend Biotech was Joint Steering Committee Service. This segment made a revenue of $54.52M, representing 91.75% of the company's total revenue.